The cannabis industry has been reaping the benefits resulting from confirmation by U.S. President Donald Trump that his administration will not target the legal marijuana businesses in the country, resulting in a rush of investors pouring into the public markets.

It all started when Sen. Cory Gardner announced on Friday (April 13) Trump himself had promised he would not target the cannabis industry in any way, momentarily removing the cloud of uncertainty reigning over legal marijuana in the U.S. due to the rescission of the Cole memo by Attorney General Jeff Sessions.

The Republican official from Colorado said in a statement he received a “commitment” from Trump last Wednesday (April 11), protecting the legal market in Colorado.

“Late Wednesday, I received a commitment from the President that the Department of Justice’s rescission of the Cole memo will not impact Colorado’s legal marijuana industry,” Gardner said.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Gardner had faced the Trump administration’s position on cannabis by blocking votes for appointments in the Department of Justice (DOJ). The Colorado representative officially ceased his holds on the nominees for DOJ.

The reaction to the news caused celebration online and a buying increase in the public markets seen across the board.

Trump’s promise boosts cannabis stocks

The North American Marijuana Index, which tracks over 40 cannabis stocks across Canadian and U.S. stock exchanges, tracked positive in early trading for Monday (April 16). At the time of this writing, this index was up 4.34 percent for the day.

Another indicator of the overall cannabis industry performance is the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ), which on Friday ended with a rush of 6.40 percent over the trading day. So far on Monday (April 16), the index has reached C$17.14, representing a 3.25 percent increase for the day

The rush in the market was felt all over the industry, but the predominant winners of this announcement are companies operating cannabis businesses in the U.S. already.

Some of the leaders in this space include the recently launched Cannex (CSE:CNNX), a company that closed on Friday with a price of C$1.33 per share. CannaRoyalty (CSE:CRZ; OTC:CNNRF) finished the trading day with a 12 percent increase, amounting to a C$0.45 gain for its Canadian stock.

Other U.S. operators listed in Canada, like MPX Bioceuticals (CSE:MPX; OTC:MPXEF) and iAnthus Capital Holdings (CSE:IAN; OTCQB:ITHUF) and Friday Night Inc. (CSE:TGIF) went up 22.22 percent, 8.49 percent, and 18.18 percent, respectively on Friday.

The CEO of FinCanna Capital (CSE:CALI; OTCQB:FNNZF), Andriyko Herchak, issued a statement in response to the Gardner announcement:

“While a bill has not yet been finalized, we feel these words of commitment from President Trump to a hands-off approach on states that legalized marijuana is extremely positive and should continue to create further comfort and momentum for investors looking to be a part of the licensed cannabis movement in the United States.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Friday Night Inc and FinCanna Capital are clients of the Investing News Network. This article is not paid-for content.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

First Units on Sale Today at Newburgh Dispensary with Availability Tomorrow at Carle Place , Forest Hills , and Plattsburgh Locations

With Enough Product to Supply Wholesale Partners by Month’s End

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day.

Keep reading... Show less

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in two upcoming events hosted by Microdose:

  • Psychedelic Capital to be held virtually on Thursday, October 28, 2021 . Payton Nyquvest , Founder and CEO of Numinus, will present at 1:45 p.m. ET . To attend, please register here .
  • Wonderland: Miami to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 8-9, 2021 . Mr. Nyquvest and Dr. Evan Lewis , Founder & Director of the Neurology Centre of Toronto , will give a presentation called Psychedelic Neurology in the Treatment of Trauma on Monday, November 8 at 4:40 p.m. ET . In addition, Sharan Sidhu , Science Officer & General Manager of Numinus, will participate in the Patent Wars panel on Tuesday, November 9 at 4:30 p.m. ET . To attend, please register here .

For more information about the events or to schedule a one-on-one meeting with Numinus‘ management, please contact KCSA Strategic Communications at .

Keep reading... Show less

Florida’s leading cannabis company to open three new Miami dispensaries

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), the largest multi-state operator (MSO) in the United States today announced the reopening of three medical marijuana dispensaries in Miami, Florida . The locations were formerly branded as Harvest House of Cannabis.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in Tallahassee, Florida. Tallahassee is Cresco Labs’ first location in the Panhandle, 10 th in Florida and 39 th nationwide.

This press release features multimedia. View the full release here:

Keep reading... Show less